The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

Despite relentless FII outflows, select Indian stocks saw increased foreign interest in the December ended —here’s where ...

Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance.

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition ... which is available in vial form or as a disposable pen. Sanofi fights back This represents Sanofi's first foray into ...

Each Soliqua 100/33 pen contains 3 milliliters (mL) of solution, with 300 units of insulin and 99 micrograms (mcg) of lixisenatide per pen. (This is 100 units of insulin and 33 mcg of lixisenatide ...

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Humulin R is available in two strengths: U-100, which contains 100 units of insulin ... that you’ll use with insulin syringes 3-mL disposable, prefilled injection pens called a KwikPens Note ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients. Weekly injections of the GLP-1 receptor agonist exenatide (Byetta, ...

Medtronic's diabetes care unit, the most impressive in terms of sales growth, is gaining prominence and still has plenty of room to grow. Medtronic develops innovative insulin pumps and pens ...